Home page of The Cochrane Collaboration

Home

Cochrane Gynaecological Cancer Group

Our Reviews

Full list:

By subtopic:

Gynaecological Cancer Group (149)
CANCER OF THE UTERINE CERVIX (27)
Diagnosis (2)
Sentinel node biopsy for diagnosis of pelvic lymph node involvement in early stage cervical cancer (protocol stage)
Triage with human papillomavirus (HPV) testing versus repeat cytology for underlying high-grade cervical intra-epithelial neoplasia in women with minor cytological lesions (protocol stage)
Prevention (2)
Interventions for encouraging sexual behaviours intended to prevent cervical cancer
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors (protocol stage)
Immunisation strategies (HPV) to prevent cervical cancer (0)
Psychosocial interventions (1)
Interventions for reducing anxiety in women undergoing colposcopy
Screening (3)
Collection devices for obtaining cervical cytology samples
Cytology versus HPV testing for cervical cancer screening in the general population (protocol stage)
Interventions targeted at women to encourage the uptake of cervical screening
Strategies and implementation for pre-malignant changes (5)
Anti-inflammatory agents for preventing the progression of cervical intraepithelial neoplasia (protocol stage)
Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia
Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatment (protocol stage)
Retinoids for preventing the progression of cervical intra-epithelial neoplasia
Surgery for cervical intraepithelial neoplasia
Initial management of invasive cancer (9)
Follow up (1)
Follow up protocols for women with cervical cancer after primary treatment (protocol stage)
Radiotherapy (0)
Surgery (1)
Laparoscopically assisted radical vaginal hysterectomy versus abdominal radical hysterectomy for the treatment of early cervical cancer (protocol stage)
Combined modality therapy (5)
Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix
Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix
Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer
Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis
Neoadjuvant chemotherapy (1)
Neoadjuvant chemotherapy for locally advanced cervix cancer
Adjuvant chemotherapy (1)
Adjuvant platinum-based chemotherapy for early stage cervical cancer
Management of advanced disease (5)
Combined modality therapy (0)
Radiotherapy (3)
Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer
Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer
Chemotherapy (1)
Chemotherapy for metastatic and recurrent cervical cancer (protocol stage)
Surgery (1)
Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer
Management of uncommon histologies (0)
CANCER OF THE OVARY (28)
Diagnosis (0)
Prevention (0)
Screening (0)
Initial management and follow-up (13)
Immunotherapy (1)
Maintenance bioimmunotherapy for epithelial ovarian cancer (protocol stage)
Surgery (2)
Laparoscopy versus laparotomy for FIGO Stage I ovarian cancer
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer
Radiotherapy (1)
Chemotherapy and/or radiotherapy after surgery for ovarian carcinosarcoma (protocol stage)
Chemotherapy (5)
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer
Chemotherapy and/or radiotherapy after surgery for ovarian carcinosarcoma (protocol stage)
Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer
Maintenance chemotherapy for ovarian cancer
Topotecan for ovarian cancer
Hormonal therapy (1)
Antigen-specific active immunotherapy for ovarian cancer
Combined modality therapy (2)
Effectiveness of different treatment modalities for the management of adult onset granulosa cell tumours of the ovary (primary and recurrent) (protocol stage)
Interventions for the treatment of borderline ovarian tumours
Follow-up (1)
Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment
Management of advanced disease (15)
Surgery (4)
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
Interval debulking surgery for advanced epithelial ovarian cancer
Optimal primary surgical treatment for advanced epithelial ovarian cancer
Surgical cytoreduction for recurrent epithelial ovarian cancer (protocol stage)
Radiotherapy (0)
Chemotherapy (9)
Angiogenesis inhibitors for the treatment of ovarian cancer
Chemotherapy for advanced ovarian cancer
Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease
Chemotherapy for relapsed epithelial ovarian cancer (protocol stage)
DNA-repair pathway inhibitors for the treatment of ovarian cancer
Epidermal growth factor receptor blockers for the treatment of ovarian cancer
Gemcitabine for platinum-resistant or recurrent ovarian cancer (protocol stage)
Pegylated liposomal doxorubicin for relapsed ovarian cancer (protocol stage)
Taxane monotherapy for the treatment of platinum pre-treated epithelial ovarian cancer (protocol stage)
Hormonal therapy (1)
Tamoxifen for relapse of ovarian cancer
Combined modality therapy (1)
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
CANCER OF THE UTERINE BODY (9)
Prevention (0)
Screening (0)
Initial management (6)
Hormone therapy (1)
Hormone replacement therapy for women previously treated for endometrial cancer (protocol stage)
Mixed modalities (0)
Surgery (2)
Laparoscopy versus laparotomy for the management of endometrial cancer (protocol stage)
Lymphadenectomy for the management of endometrial cancer
Radiotherapy (1)
Adjuvant radiotherapy for stage I endometrial cancer
Chemotherapy (2)
Adjuvant chemotherapy for endometrial cancer after hysterectomy
Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma
Management of advanced disease (2)
Hormonal therapy (2)
Adjuvant progestagens for endometrial cancer
Hormonal therapy in advanced or recurrent endometrial cancer
Mixed modalities (0)
Chemotherapy (1)
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
Management of uncommon histologies (0)
CANCER OF THE VULVA (6)
Prevention (0)
Screening (0)
Management of initial and advanced disease (3)
Surgery (1)
Surgical interventions for early squamous cell carcinoma of the vulva
Radiotherapy (1)
Primary groin irradiation versus primary groin surgery for early vulvar cancer
Chemotherapy (0)
Combined modality therapy (1)
Chemoradiation for advanced primary vulval cancer
Strategies and implementation for pre-malignant changes (3)
Interventions for the treatment of Paget's disease of the vulva (protocol stage)
Medical interventions for high grade vulval intraepithelial neoplasia
Surgical interventions for high grade vulval intraepithelial neoplasia
CANCER OF THE VAGINA (0)
Management of vaginal intraepithelial neoplasia (VAIN) (0)
Screening (0)
Treatment (0)
Management of invasive cancer (0)
Surgery (0)
Radiotherapy (0)
Chemotherapy (0)
Combined modality therapy (0)
SURGICAL TECHNIQUES FOR GYNAECOLOGICAL CANCER (1)
Robotic assisted surgery for gynaecological cancer (protocol stage)
TROPHOBLASTIC TUMOURS (1)
Prevention- management of hydatidiform mole (0)
Management of invasive cancer (1)
Surgery (0)
Radiotherapy (0)
Chemotherapy (1)
Combination chemotherapy for high-risk gestational trophoblastic tumour
CANCER OF THE FALLOPIAN TUBE (0)
Management of initial and advanced disease (0)
MISCELLANEOUS GYNAECOLOGICAL CANCER TOPICS (13)
Gestational trophoblastic neoplasia (3)
Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia (protocol stage)
First line chemotherapy in low risk gestational trophoblastic neoplasia
Prophylactic chemotherapy for hydatidiform mole (protocol stage)
Infertility and gynaecological cancer (3)
Conservative treatments in gynaecological cancer for fertility preservation (protocol stage)
Obstetric outcomes and fertility after conservative treatment for cervical intraepithelial lesions (protocol stage)
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility (protocol stage)
Management of service providers of gynaecological cancer (2)
Centralisation of services for gynaecological cancer (protocol stage)
Perioperative enhanced recovery programmes for gynaecological cancer patients
Treatment of postoperative morbidities (1)
Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies
Treatment of symptoms of advanced gynaecological cancer (2)
Management of drainage for malignant ascites in gynaecological cancer
Palliative surgery versus medical management for bowel obstruction in ovarian cancer
Tumour markers in gynaecological cancer (0)
Psychosexual dysfunction due to treatment for cancer (2)
Interventions for psychosexual dysfunction in women treated for gynaecological malignancy
Vaginal dilator therapy for women receiving pelvic radiotherapy
'ORPHAN' TOPICS CURRENTLY BEING ADDRESSED (64)
Neurological oncology (13)
Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas
Anti-angiogenic therapy for high grade glioma (protocol stage)
Biopsy versus resection for high grade glioma
Biopsy versus resection for the management of low-grade gliomas (protocol stage)
Chemotherapy for high-grade glioma
Chemotherapy wafers for high grade glioma
Early versus delayed radiotherapy for the treatment of low-grade gliomas (protocol stage)
Pharmacological treatment of depression in patients with a primary brain tumour
Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases (protocol stage)
Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases
Temozolomide for High Grade Glioma
Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases
Whole brain radiotherapy for the treatment of multiple brain metastases
Soft tissue sarcoma (3)
Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults
Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas
Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma
Infections in neutropenic cancer patients (16)
Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients
Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction
Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction
Influenza vaccines for prevention of influenza-like illness and influenza in immunosuppressed cancer patients (protocol stage)
Nystatin prophylaxis and treatment in severely immunodepressed patients
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
Outpatient treatment for patients with cancer who develop a low-risk febrile neutropenic event (protocol stage)
Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients
Routine versus selective antifungal administration for control of fungal infections in patients with cancer
Voriconazole versus amphotericin B in cancer patients with neutropenia
Drug therapies for cancers of similar histological type (2)
Chemotherapy for thymic carcinoma and advanced thymoma in adults (protocol stage)
Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma
Enzyme therapy (0)
Complementary therapies for cancer (6)
Ganoderma Lucidum (Reishi mushroom) for cancer treatment (protocol stage)
Green tea (Camellia sinensis) for the prevention of cancer
Laetrile treatment for cancer
Mistletoe therapy in oncology
Selenium for preventing cancer
Thymic peptides for treatment of cancer patients
Supportive interventions for cancer patients (9)
Exercise interventions on health related quality of life for people with cancer during active treatment (protocol stage)
Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy
Multidimensional rehabilitation programmes for adult cancer survivors (protocol stage)
Music interventions for improving psychological and physical outcomes in cancer patients
Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis
Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis
Psychological interventions for cancer survivors and cancer patients in the palliative phase (protocol stage)
Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients (protocol stage)
Telephone interventions for symptom management in adults with cancer (protocol stage)
Training interventions for cancer carers and professionals (1)
Communication skills training for health care professionals working with cancer patients, their families and/or carers
Treatment of miscellaneous conditions in cancer (9)
Anticoagulation for patients with cancer and central venous catheters
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer (protocol stage)
Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation
Polymerase chain reaction tests for the diagnosis of invasive aspergillosis in immunocompromised patients (protocol stage)
Probiotics for the prevention or treatment of chemotherapy or radiotherapy related diarrhoea in cancer patients (protocol stage)
Thalidomide for managing cancer cachexia (protocol stage)
Techniques to modulate the effects of chemotherapy and/or radiotherapy (5)
Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy
Hyperbaric oxygen therapy for late radiation tissue injury
Hyperbaric oxygenation for tumour sensitisation to radiotherapy